Quick Answer
Xenetic Biosciences, Inc. reported Total Revenue of $2.98 million for fiscal year 2025.
Xenetic Biosciences, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $2.98M | +19.0% |
| 2024 | $2.50M | -1.6% |
| 2023 | $2.54M | +48.8% |
| 2022 | $1.71M | +47.1% |
| 2021 | $1.16M | +165.6% |
| 2020 | $436.9K | +2460.3% |
| 2019 | $17.1K | — |
| 2018 | $0.00 | -100.0% |
| 2017 | $7.58M | +152.8% |
| 2016 | $3.00M | — |
| 2015 | $0.00 | — |
| 2014 | $0.00 | -100.0% |
| 2013 | $1.00M | +932.0% |
| 2013 | $96.9K | -14.1% |
| 2012 | $112.8K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.03M | +67.2% | +74.1% |
| June 30, 2025 | $589.9K | -18.8% | -0.6% |
| March 31, 2025 | $593.3K | +16.1% | -3.4% |
| September 30, 2024 | $614.2K | +0.5% | -15.4% |
| June 30, 2024 | $726.4K | +11.6% | +42.2% |
| March 31, 2024 | $510.8K | -15.7% | -16.4% |
| September 30, 2023 | $611.2K | +47.5% | -6.1% |
| June 30, 2023 | $651.0K | +56.2% | +7.5% |
- Xenetic Biosciences, Inc. showed an increase of +19.0% in Total Revenue compared to the prior fiscal year.
- Over the 2012–2025 period, Xenetic Biosciences, Inc.’s total revenue has grown by 2539.0% (from $112.8 thousand to $2.98 million).
- The most recent figure is from Xenetic Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: